טוען...
Perampanel overdose in low body mass index patients with epilepsy: a case report and review of the literature
BACKGROUND: Perampanel (PER) is a novel antiepileptic drug (AED) which employs a completely different mechanism of action compared to existing medications. Overall, PER is considered to be safe up to a dose of 12 mg per day. When used to treat refractory and super-refractory status epilepticus, PER...
שמור ב:
| הוצא לאור ב: | J Med Case Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006340/ https://ncbi.nlm.nih.gov/pubmed/33775251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02759-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|